Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10526313 Rho kinase inhibitor BA-1049 (R) and active metabolites thereof

Patent 10526313 was granted and assigned to BioAxone Biosciences on January, 2020 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

‌

Bioaxone Biosciences, Inc.

Current Assignee

‌

BioAxone Biosciences

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

105263130

Patent Inventor Names

Matthew D. Abbinanti0

Joerg Ruschel0

Kenneth M. Rosen0

Lisa Bond Moritz0

Lisa Mckerracher0

Date of Patent

January 7, 2020

Patent Application Number

159887360

Date Filed

May 24, 2018

Patent Citations

‌

US Patent 10106525 Rho kinase inhibitor BA-1049 (R) and active metabolites thereof

‌

US Patent 10149856 Treatment of cerebral cavernous malformations and cerebral aneurysms with rho kinase inhibitors

Patent Citations Received

‌

US Patent 11407559 Pipe coil skid with side rails and method of use

‌

US Patent 11701366 Treatment of cerebral cavernous malformations and cerebral aneurysms with rho kinase inhibitors

Patent Primary Examiner

‌

San Ming R Hui

Patent abstract

BA-1049 (R) and its active metabolite are disclosed. Also disclosed are pharmaceutical formulations containing BA-1049 (R) or its active metabolite.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10526313 Rho kinase inhibitor BA-1049 (R) and active metabolites thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API